We are live on ! Find out more
ERNA icon

Eterna Therapeutics
ERNA

7 hedge funds and large institutions have $9.86M invested in Eterna Therapeutics in 2014 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more capital invested

Capital invested by funds: $5.69M → $9.86M (+$4.18M)

40% more funds holding

Funds holding: 5 → 7 (+2)

Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
+$4.83M
2
EAM
Eagle Asset Management
Florida
+$440K
3
PCM
Perritt Capital Management
Illinois
+$440K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$440K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AWMDMG
1
Austin W. Marxe & David M. Greenhouse
New York
$4.22M +$4.83M +11 New
EAM
2
Eagle Asset Management
Florida
$2.19M +$440K +1 +20%
MHP
3
Manatuck Hill Partners
Connecticut
$995K – – –
GPCM
4
Granite Point Capital Management
Massachusetts
$588K – – –
PCM
5
Perritt Capital Management
Illinois
$584K +$440K +1 New
Renaissance Technologies
6
Renaissance Technologies
New York
$408K – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$331K +$440K +1 New
State of New Jersey Common Pension Fund D
8
State of New Jersey Common Pension Fund D
New Jersey
$159K – – –
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$118K – – –
BIT
10
BlackRock Institutional Trust
California
$66K – – –
OC
11
Oppenheimer & Co
New York
$59K – – –
Goldman Sachs
12
Goldman Sachs
New York
$54K – – –
Geode Capital Management
13
Geode Capital Management
Massachusetts
$26K – – –
Northern Trust
14
Northern Trust
Illinois
$18K – – –
U
15
UBS
Switzerland
$16K – – –
CL
16
CSS LLC
Illinois
$9K – – –
VKH
17
Virtu KCG Holdings
New York
$8K – – –
Manulife (Manufacturers Life Insurance)
18
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4K – – –
Morgan Stanley
19
Morgan Stanley
New York
$3K – – –
Citigroup
20
Citigroup
New York
$1K – – –

ERNA Hedge Fund Activity: Q2 2014 in Review

7 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q2 2014, worth a combined $9.86M — up 73% from $5.69M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new ERNA positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Austin W. Marxe & David M. Greenhouse, opening a new position worth an estimated $4.83M.

  • 7 institutional investors held Eterna Therapeutics (ERNA) as of Q2 2014, up from 5 in Q1 2014.
  • Funds reported $9.86M of Eterna Therapeutics stock for Q2 2014, up 73% quarter-over-quarter.
  • 3 funds opened new Eterna Therapeutics positions in Q2 2014 and 0 closed out, a net change of +3 holders.
  • The largest Eterna Therapeutics buyer in Q2 2014 was Austin W. Marxe & David M. Greenhouse, an estimated $4.83M added.

Based on aggregated 13F filings for Q2 2014.